Erschienen in:
28.06.2019 | Commentary
Expanding the boundaries of point of care testing
verfasst von:
Thomas J. Morgan, Christopher M. Anstey
Erschienen in:
Journal of Clinical Monitoring and Computing
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Excerpt
Point of care (POC) or ‘near patient’ testing refers to testing and reporting at the site of patient care, usually by non-laboratory or where applicable by non-imaging personnel. Although now a growth industry, the POC concept is not new. Modalities brought to the bedside in decades past have included ultrasonography [
1], echocardiography [
2], pulse oximetry [
3], and intra-arterial [
4] and transcutaneous [
5] as well as benchtop blood gas monitoring. Current applications are legion, whether wearable, hand-held or benchtop devices [
6]. To cite just a few we have glycosylated haemoglobin analysis [
7], pulse co-oximetry [
8], thrombo-elastography [
9], therapeutic drug and drugs of abuse screening [
10], tests for malaria, tubercle bacillus and the dengue virus [
11] and cartridge-based analysers offering suites of tests such as blood gas analysis, electrolyte and urea/creatinine panels, haematocrit and coagulation testing, rapid cardiac markers and β-HCG assays [
12,
13]. …